Campbell & Co Investment Adviser’s Core Laboratories CLB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-40,374
Closed -$678K 1074
2026
Q1
$678K Buy
40,374
+19,895
+97% +$356K 0.04% 647
2025
Q4
$328K Buy
20,479
+5,116
+33% +$76.1K 0.02% 955
2025
Q3
$190K Sell
15,363
-10,468
-41% -$123K 0.01% 1011
2025
Q2
$298K Buy
+25,831
New +$306K 0.02% 955
2024
Q2
Sell
-15,501
Closed -$265K 1080
2024
Q1
$265K Sell
15,501
-45,341
-75% -$713K 0.02% 949
2023
Q4
$1.07M Sell
60,842
-12,842
-17% -$259K 0.1% 356
2023
Q3
$1.77M Buy
+73,684
New +$1.81M 0.21% 115
2021
Q2
Sell
-14,250
Closed -$410K 548
2021
Q1
$410K Buy
+14,250
New +$487K 0.25% 137
2020
Q4
Sell
-13,670
Closed -$209K 436
2020
Q3
$209K Buy
+13,670
New +$287K 0.16% 299
2020
Q1
Sell
-11,398
Closed -$429K 111
2019
Q4
$429K Buy
+11,398
New +$512K 0.13% 282
2014
Q3
Sell
-14,196
Closed -$2.37M 198
2014
Q2
$2.37M Buy
+14,196
New +$2.53M 0.95% 44
2013
Q3
Sell
-4,555
Closed -$691K 260
2013
Q2
$691K Buy
+4,555
New +$645K 0.13% 179

Other funds holding CLB

Campbell & Co Investment Adviser's CLB Position: Q2 2026 in Review

Campbell & Co Investment Adviser sold out of Core Laboratories (CLB) in Q2 2026, closing a stake of 40,374 shares — an estimated $678K sold.

Campbell & Co Investment Adviser first reported a position in CLB in Q2 2013 and held it in 12 quarters. The position peaked at $2.37M in Q2 2014. 77 funds tracked by Wall St. Rank hold CLB as of Q2 2026.

  • Campbell & Co Investment Adviser reported no remaining Core Laboratories position as of Q2 2026 after selling out during the quarter.
  • Campbell & Co Investment Adviser sold 40,374 Core Laboratories shares in Q2 2026, an estimated $678K.
  • Campbell & Co Investment Adviser first reported a position in Core Laboratories in Q2 2013 and held it in 12 quarters.
  • Campbell & Co Investment Adviser's Core Laboratories position peaked at $2.37M in Q2 2014.
  • 77 funds tracked by Wall St. Rank held Core Laboratories as of Q2 2026.

Based on Campbell & Co Investment Adviser's 13F filing for Q2 2026, filed 3 Aug 2026.